Nirvanappa, A. C., Mohan, C. D., Rangappa, S., Ananda, H., Sukhorukov, A. Y., Shanmugam, M. K., . . . PHARMACOLOGY. (2022). Correction: Novel Synthetic Oxazines Target NF-kappa B in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo (vol 11, e0163209, 2016). PUBLIC LIBRARY SCIENCE.
Chicago Style CitationNirvanappa, Anilkumar C., et al. Correction: Novel Synthetic Oxazines Target NF-kappa B in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo (vol 11, E0163209, 2016). PUBLIC LIBRARY SCIENCE, 2022.
MLA引文Nirvanappa, Anilkumar C., et al. Correction: Novel Synthetic Oxazines Target NF-kappa B in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo (vol 11, E0163209, 2016). PUBLIC LIBRARY SCIENCE, 2022.
警告：這些引文格式不一定是100％准確.